We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Biohaven
BHVN
$2.18B
| $1.16M | ﹤0.01% |
136,883
+20,286
| +17% | +$222K |
|
2052
Taysha Gene Therapies
TSHA
$1.59B
| $1.16M | ﹤0.01% |
258,530
+1,090
| +0.4% | +$5.07K |
|
2053
The RealReal
REAL
$1.4B
| $1.15M | ﹤0.01% |
126,351
+3,993
| +3% | +$50.5K |
|
2054
First Financial Corp
THFF
$924M
| $1.14M | ﹤0.01% |
18,092
+1,823
| +11% | +$116K |
|
|
PVLA
2055
Palvella Therapeutics
PVLA
$2.03B
| $1.14M | ﹤0.01% |
9,129
+493
| +6% | +$51.4K |
|
2056
Genius Sports
GENI
$1.94B
| $1.14M | ﹤0.01% |
256,735
-9,356
| -4% | -$66.6K |
|
2057
CareDx
CDNA
$1.88B
| $1.14M | ﹤0.01% |
65,500
-3,698
| -5% | -$70K |
|
|
MIAX
2058
Miami International Holdings
MIAX
$4.2B
| $1.14M | ﹤0.01% |
29,210
+1,860
| +7% | +$76.6K |
|
2059
Revolve Group
RVLV
$1.84B
| $1.14M | ﹤0.01% |
50,258
-938
| -2% | -$24.6K |
|
2060
ORIX
IX
$43.9B
| $1.13M | ﹤0.01% |
37,647
+2,368
| +7% | +$75.1K |
|
2061
N-able
NABL
$823M
| $1.12M | ﹤0.01% |
240,508
+10,919
| +5% | +$61K |
|
2062
Forward Air
FWRD
$466M
| $1.12M | ﹤0.01% |
67,106
+1,613
| +2% | +$39.3K |
|
2063
NB Bancorp
NBBK
$983M
| $1.12M | ﹤0.01% |
53,175
+964
| +2% | +$20.3K |
|
2064
Corvus Pharmaceuticals
CRVS
$1.09B
| $1.12M | ﹤0.01% |
76,514
+5,787
| +8% | +$92.4K |
|
2065
Royal Bank of Canada
RY
$291B
| $1.12M | ﹤0.01% |
6,918
-8
| -0.1% | -$1.34K |
|
2066
Dream Finders Homes
DFH
$1.43B
| $1.12M | ﹤0.01% |
80,400
+2,255
| +3% | +$40.1K |
|
2067
Allient
ALNT
$1.47B
| $1.12M | ﹤0.01% |
18,878
-207
| -1% | -$13K |
|
2068
Limbach Holdings
LMB
$886M
| $1.11M | ﹤0.01% |
14,276
-184
| -1% | -$15.5K |
|
2069
Cytek Biosciences
CTKB
$570M
| $1.11M | ﹤0.01% |
254,589
+4,649
| +2% | +$21.9K |
|
2070
Universal Insurance Holdings
UVE
$1.21B
| $1.11M | ﹤0.01% |
32,544
-546
| -2% | -$17.6K |
|
2071
Oil States International
OIS
$512M
| $1.11M | ﹤0.01% |
95,417
-3,168
| -3% | -$32.7K |
|
2072
Xeris Biopharma Holdings
XERS
$1.42B
| $1.11M | ﹤0.01% |
191,067
+1,500
| +0.8% | +$9.95K |
|
|
ASMI
2073
DELISTED
ASM INTERNATL N.V
ASMI
| $1.1M | ﹤0.01% |
1,465
+76
| +5% | +$57.3K |
|
2074
Amalgamated Financial
AMAL
$1.46B
| $1.1M | ﹤0.01% |
28,360
-286
| -1% | -$10.8K |
|
2075
Northeast Bank
NBN
$1.14B
| $1.1M | ﹤0.01% |
9,795
+10
| +0.1% | +$1.13K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.